About Receptor
Psychedelics will have a significant global impact by introducing novel and effective treatments for depression, addiction, PTSD, anxiety and other mental health disorders. Receptor invests in this new biotech ecosystem through early and mid stage drug discovery companies.
Investment Details
Investment Range
Not specified
Investment Stage
Various stages
Industry Focus
Biopharma, Climate, Healthcare (+2 more)
Investor Type
Private Equity Firm, Venture Capital
Investment Focus
Focus Areas
Investment Stages